Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


2 Am Heart J
2 Am J Cardiol
5 Am J Emerg Med
1 Ann Thorac Surg
1 Circ Arrhythm Electrophysiol
1 Circ Cardiovasc Interv
1 Circ Res
3 Circulation
1 Clin Cardiol
3 Int J Cardiol
7 J Cardiol
3 J Cardiovasc Pharmacol
1 J Electrocardiol
1 J Emerg Med
2 J Interv Card Electrophysiol
2 Pacing Clin Electrophysiol
6 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. ANTONIO GUTIERREZ J, Ruff CT, Aday AW, Gu L, et al
    Electronic Alerts to Initiate Anticoagulation Dialogue in Patients with Atrial Fibrillation.
    Am Heart J. 2021 Nov 19. pii: S0002-8703(21)00452.
    PubMed         Abstract available

  2. CHEW DS, Li Z, Steinberg BA, O'Brien E, et al
    Association between Economic and Arrhythmic Burden of Paroxysmal Atrial Fibrillation in Patients with Cardiac Implanted Electronic Devices.
    Am Heart J. 2021 Nov 17. pii: S0002-8703(21)00450.
    PubMed         Abstract available

    Am J Cardiol

  3. SHAH KB, Saado J, Kerwin M, Mazimba S, et al
    Meta-Analysis of New-Onset Atrial Fibrillation Versus No History of Atrial Fibrillation in Patients With Noncardiac Critical Care Illness.
    Am J Cardiol. 2021 Nov 20. pii: S0002-9149(21)01055.
    PubMed         Abstract available

  4. ZAFFALON D, Pagura L, Cannata A, Barbati G, et al
    Supraventricular Tachycardia Causing Left Ventricular Dysfunction.
    Am J Cardiol. 2021;159:72-78.
    PubMed         Abstract available

    Am J Emerg Med

  5. BARMAN HA, Atici A, Sahin I, Dogan O, et al
    Prognostic value of right ventricular strain pattern on ECG in COVID-19 patients.
    Am J Emerg Med. 2021;49:1-5.
    PubMed         Abstract available

  6. QI Z, Yang S, Li M, Qu J, et al
    Risk factors and predictors of QTc prolongation in critically ill Chinese patients.
    Am J Emerg Med. 2021;49:24-28.
    PubMed         Abstract available

  7. ROBISON LB, Brady WJ, Robison RA, Charlton N, et al
    QT interval prolongation and the risk of malignant ventricular dysrhythmia and/or cardiac arrest: Systematic search and narrative review of risk related to the magnitude of QT interval length.
    Am J Emerg Med. 2021;49:40-47.
    PubMed         Abstract available

  8. NABER CE, Acholonu NO, Fernandes ND, Sanders BP, et al
    Ventricular tachycardia after naloxone administration in an adolescent.
    Am J Emerg Med. 2021;49:300-301.
    PubMed         Abstract available

  9. HOWARD MB, Basu S, Sherwin E, Cohen JS, et al
    Triple threat: New presentation with diabetic ketoacidosis, COVID-19, and cardiac arrhythmias.
    Am J Emerg Med. 2021;49:437.
    PubMed         Abstract available

    Ann Thorac Surg

    The Cox-Maze Procedure: Rules Not To Be Broken.
    Ann Thorac Surg. 2021;112:2109.


  11. EVANS E, Swanson MB, Mohr N, Boulos N, et al
    Epinephrine before defibrillation in patients with shockable in-hospital cardiac arrest: propensity matched analysis.
    BMJ. 2021;375:e066534.
    PubMed         Abstract available

    Circ Arrhythm Electrophysiol

  12. LEI LY, Chew DS, Lee W, Meng Z, et al
    Pharmacological Cardioversion of Atrial Tachyarrhythmias Using Single High-Dose Oral Amiodarone: a Systematic Review and Meta-Analysis.
    Circ Arrhythm Electrophysiol. 2021 Nov 22:CIRCEP121010321.

    Circ Cardiovasc Interv

  13. YOO DH, Gibson DN, Funk J, Pangborn K, et al
    Treatment and Outcomes of Device-Related Thrombus After Transcatheter Left Atrial Appendage Closure.
    Circ Cardiovasc Interv. 2021;14:e010889.

    Circ Res

  14. GHIGO A, Harvey RD
    Illuminating cAMP Dynamics at Ryanodine Receptors in Arrhythmias.
    Circ Res. 2021;129:95-97.


  15. KANAGASUNDRAM AN, Richardson TD, Stevenson WG
    The Heart Rate of Ventricular Tachycardia.
    Circulation. 2021;143:227-229.

  16. AGUILAR M, Macle L, Deyell MW, Yao R, et al
    The Influence of Monitoring Strategy on Assessment of Ablation Success and Post-ablation Atrial Fibrillation Burden Assessment: Implications for Practice and Clinical Trial Design.
    Circulation. 2021 Nov 24. doi: 10.1161/CIRCULATIONAHA.121.056109.
    PubMed         Abstract available

  17. SCHMIDT AS, Lauridsen KG, Moller DS, Christensen PD, et al
    Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation.
    Circulation. 2021 Nov 24. doi: 10.1161/CIRCULATIONAHA.121.056301.
    PubMed         Abstract available

    Clin Cardiol

  18. SIMON J, El Mahdiui M, Smit JM, Szaraz L, et al
    Left atrial appendage size is a marker of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with persistent atrial fibrillation.
    Clin Cardiol. 2021 Nov 19. doi: 10.1002/clc.23748.
    PubMed         Abstract available

    Int J Cardiol

  19. TAKAYA Y, Nakamura K, Nishii N, Ito H, et al
    Clinical outcomes of patients with isolated cardiac sarcoidosis confirmed by clinical diagnostic criteria.
    Int J Cardiol. 2021;345:49-53.
    PubMed         Abstract available

  20. DI LULLO L, Lavalle C, Magnocavallo M, Mariani MV, et al
    New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulation.
    Int J Cardiol. 2021;345:90-97.
    PubMed         Abstract available

  21. NSO N, Nassar M, Lakhdar S, Enoru S, et al
    Comparative assessment of transvenous versus subcutaneous implantable cardioverter-defibrillator therapy outcomes: An updated systematic review and meta-analysis.
    Int J Cardiol. 2021 Nov 18. pii: S0167-5273(21)01846.
    PubMed         Abstract available

    J Cardiol

  22. TOPAZ G, Ben-Zvi E, Pereg D, Kitay-Cohen Y, et al
    Prediction of acute-coronary-syndrome using newly-defined R2-CHA2DS2-VASc score among patients with chest pain.
    J Cardiol. 2021;77:370-374.
    PubMed         Abstract available

  23. INOUE K, Hirao K, Kumagai K, Kimura M, et al
    Long-term efficacy and safety of anticoagulation after atrial fi brillation ablation: data from the JACRE registry.
    J Cardiol. 2021;77:263-270.
    PubMed         Abstract available

  24. ASHER E, Abu-Much A, Bragazzi NL, Younis A, et al
    CHADS2 and CHA2DS2-VASc scores as predictors of platelet reactivity in acute coronary syndrome.
    J Cardiol. 2021;77:375-379.
    PubMed         Abstract available

  25. OKISHIGE K, Yamauchi Y, Nagase S, Kusano K, et al
    Transcatheter cryo-ablation of septal accessory pathways, multicenter observational study in Japan.
    J Cardiol. 2021;77:380-387.
    PubMed         Abstract available

  26. ABE Y, Takahashi Y, Shibata T
    A new disease entity: Atrial functional mitral regurgitation.
    J Cardiol. 2021;77:565-569.
    PubMed         Abstract available

  27. KATO A, Sato J, Yoshii K, Yoshida S, et al
    The mid-term outcome of Fontan conversion compared with primary total cavopulmonary connection.
    J Cardiol. 2021;78:213-218.
    PubMed         Abstract available

  28. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    PubMed         Abstract available

    J Cardiovasc Pharmacol

  29. ZHENG RJ, Wang Y, Tang JN, Duan JY, et al
    Association of SGLT2 inhibitors with risk of atrial fibrillation and stroke in patients with and without type 2 diabetes: a systemic review and meta-analysis of randomized controlled trials.
    J Cardiovasc Pharmacol. 2021 Nov 22. pii: 00005344-900000000-98109.
    PubMed         Abstract available

  30. HIJAZI Y, Karkabi B, Feldman M, Malca B, et al
    Bridging care transition after hospitalization for atrial fibrillation and coronary interventions.
    J Cardiovasc Pharmacol. 2021 Nov 16. pii: 00005344-900000000-98113.
    PubMed         Abstract available

    Atrial fibrillation induced by anticancer drugs and underling mechanisms.
    J Cardiovasc Pharmacol. 2021 Nov 17. pii: 00005344-900000000-98110.
    PubMed         Abstract available

    J Electrocardiol

  32. VAN DER WERF C, Wilde AAM
    Avoiding fatal implantable cardioverter-defibrillator complications in patients with catecholaminergic polymorphic ventricular tachycardia by not implanting them.
    J Electrocardiol. 2021;70:2-3.

    J Emerg Med

  33. MOHAN S, Backus T, Furlano E, Howland MA, et al
    A Case of Massive Diphenhydramine and Naproxen Overdose.
    J Emerg Med. 2021 Jun 17. pii: S0736-4679(21)00392.
    PubMed         Abstract available

    J Interv Card Electrophysiol

  34. KRAMER AD, Korsholm K, Kristensen A, Poulsen LH, et al
    Left atrial appendage occlusion in haemophilia patients with atrial fibrillation.
    J Interv Card Electrophysiol. 2021 Nov 25. pii: 10.1007/s10840-021-01090.
    PubMed         Abstract available

  35. DOGNIN N, Salaun E, Champagne C, Domain G, et al
    Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.
    J Interv Card Electrophysiol. 2021 Nov 25. pii: 10.1007/s10840-021-01073.
    PubMed         Abstract available

    Pacing Clin Electrophysiol

  36. KAWAMURA I, Aikawa T, Yokoyama Y, Takagi H, et al
    Catheter ablation for atrial fibrillation in elderly patients: systematic review and a meta-analysis.
    Pacing Clin Electrophysiol. 2021 Nov 24. doi: 10.1111/pace.14413.
    PubMed         Abstract available

  37. AYOUB K, Fry E, Marji M, Masri A, et al
    Implantable cardioverter-defibrillators with end stage renal disease: nationwide inpatient sample database results.
    Pacing Clin Electrophysiol. 2021 Nov 22. doi: 10.1111/pace.14411.
    PubMed         Abstract available

    PLoS One

  38. PALACIO LC, Pachajoa DC, Durango-Giraldo G, Zapata-Hernandez C, et al
    Atrial proarrhythmic effect of lead as one of the PM10 metal components of air pollution. An in-silico study.
    PLoS One. 2021;16:e0258313.
    PubMed         Abstract available

  39. KIM BJ, Lee KJ, Park EL, Tanaka K, et al
    Prediction of recurrent stroke among ischemic stroke patients with atrial fibrillation: Development and validation of a risk score model.
    PLoS One. 2021;16:e0258377.
    PubMed         Abstract available

  40. LANGE M, Hirahara AM, Ranjan R, Stoddard GJ, et al
    Atrial slow conduction develops and dynamically expands during premature stimulation in an animal model of persistent atrial fibrillation.
    PLoS One. 2021;16:e0258285.
    PubMed         Abstract available

  41. STEINHUBL SR, Waalen J, Sanyal A, Edwards AM, et al
    Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening-mHealth Screening to Prevent Strokes (mSToPS).
    PLoS One. 2021;16:e0258276.
    PubMed         Abstract available

  42. NIJPELS G, van der Heijden AAWA, Elders P, Beulens JWJ, et al
    The interobserver agreement of ECG abnormalities using Minnesota codes in people with type 2 diabetes.
    PLoS One. 2021;16:e0255466.
    PubMed         Abstract available

  43. CHO JH, Leong D, Cuk N, Ebinger JE, et al
    Delayed repolarization and ventricular tachycardia in patients with heart failure and preserved ejection fraction.
    PLoS One. 2021;16:e0254641.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.